Abbott’s Healthy Food Rx program shows clinical benefits for diabetes patients in low-income settings

Abbott Laboratories (NYSE: ABT) has announced significant findings from a randomized controlled clinical trial of its Healthy Food Rx program, presented at the 85th Scientific Sessions of the American Diabetes Association (ADA). The trial results, which measured the impact of biweekly healthy food delivery and nutrition education on low-income individuals with diabetes in Stockton, California, revealed notable improvements in participants’ diet quality, perceived physical health, and glycemic control.

The study, conducted by the Public Health Institute Center for Wellness and Nutrition, is one of the few randomized trials examining a “food is medicine” model in a real-world, underserved community setting. Analysts tracking innovations in population health and health equity have highlighted the trial as a landmark in the growing convergence between nutrition policy and chronic disease treatment.

How does Abbott’s Healthy Food Rx program support low-income communities with diabetes management?

Launched in 2021 under Abbott’s Future Well™ Communities initiative, the Healthy Food Rx program was developed to address high rates of diabetes and pre-diabetes in disadvantaged regions by offering accessible nutrition. In Stockton, where approximately 60% of the population faces either diabetes or pre-diabetes, participants received home-delivered food boxes containing meal kits, fresh produce, pantry staples, and tailored educational content such as cooking videos and recipe cards.

Over six months, 364 adult participants were randomly assigned to receive the intervention or act as a control group with delayed access. The intervention group received food boxes every other week, along with structured nutrition education through digital platforms and text messaging. All participants had access to standard medical care, including prescriptions and optional diabetes education.

According to the study, the intervention group showed a statistically significant increase in daily vegetable consumption (0.37 servings per day versus 0.03 in the control group, p = 0.007) and a modest but positive change in fruit intake. Physical health self-assessments improved markedly, rising from 38% to 63% among the intervention group, a contrast to the flat progression observed in the control arm.

What clinical impact did the Healthy Food Rx program have on A1C levels and diabetes outcomes?

Hemoglobin A1C, a benchmark indicator of long-term blood glucose levels, served as the trial’s primary clinical endpoint. Both the intervention and control groups demonstrated A1C reductions that exceeded the commonly accepted threshold of 0.5%, which is associated with improved health outcomes in people with diabetes. Specifically, the intervention group achieved a 0.7% reduction, while the control group—possibly benefiting from increased engagement with standard care—saw a 1.2% drop.

These findings validate that even modest, targeted interventions can enhance glycemic control when integrated into broader care frameworks. Analysts following nutrition-based health models noted that while the A1C improvement in both groups could reflect external care factors, the additional quality-of-life gains reported in the Healthy Food Rx cohort position the program as a scalable adjunct to conventional diabetes care.

How have participants responded to Abbott’s Healthy Food Rx initiative from a satisfaction and engagement standpoint?

Satisfaction levels were overwhelmingly positive. Nearly all participants (98%) in the Healthy Food Rx program reported being satisfied with the food received, and 97% used all or most of the food items provided. Notably, two-thirds of participants shared the meals with at least two additional people, and 99% indicated they would recommend the service to others.

These engagement metrics suggest that the impact of the program extends beyond individual health markers. Community-based delivery, combined with culturally sensitive nutrition education, appeared to promote healthier habits not just among participants, but also among their families and social networks.

Experts in public health believe that the high usage and referral rates underscore the program’s cultural and logistical resonance in low-income communities, further advocating for public-private partnerships in healthcare delivery models.

What role does the Healthy Food Rx program play in shaping future chronic care strategies for underserved regions?

Institutional investors and health system analysts have increasingly emphasized the value of integrated chronic care models that merge medical treatment with socioeconomic supports. The Healthy Food Rx initiative aligns with this shift, demonstrating how preventative measures can generate both measurable health outcomes and patient satisfaction.

Abbott Fund president and Abbott SVP of Global Marketing and External Affairs, Melissa Brotz, described the program as a gateway to longer-term wellness for underserved populations. “By integrating healthy food and nutrition education as part of a broader effort to remove barriers to care, we’re helping people to feel more in control and take an active role in managing their health,” Brotz said.

Future studies may track longitudinal data to understand whether these short-term improvements translate into reduced hospitalizations or long-term disease progression. Analysts expect further investment in similar models from major healthcare players, especially those targeting Medicaid expansion states or working in partnership with federal Qualified Health Centers (FQHCs).

How does this clinical trial compare with previous evaluations of the Healthy Food Rx program?

This new clinical trial builds on a prior 12-month observational study, also conducted in Stockton, that found consistent benefits in diet quality and health engagement among participants. However, the latest trial’s randomized controlled design offers stronger evidence of causality, elevating its significance in scientific and policy discussions.

According to Erika Takada, Executive Director of the Public Health Institute Center for Wellness and Nutrition, the study’s outcome supports a fundamental truth often overlooked in chronic disease care. “Even with a program that reaches participants just twice a month, we are seeing benefits in people with diabetes eating better foods and feeling healthier,” she said.

Her remarks reflect growing institutional acknowledgment of nutrition as a core determinant of health—a sentiment echoed in national debates on Medicare expansion, food access, and preventive care reimbursement.

What are the future implications of Abbott’s food-based clinical intervention for diabetes care in the U.S.?

Abbott’s Healthy Food Rx is among the largest food-is-medicine pilots active in the U.S., having reached more than 1,700 participants since 2021. Its structured partnership with Stockton-based organizations, including Community Medical Centers and the Emergency Food Bank Stockton/San Joaquin, exemplifies a localized implementation model that may be replicated in other diabetes hotspots.

Analysts monitoring ESG metrics and community investment strategies view Abbott’s initiative as a blueprint for scalable, evidence-backed interventions that merge corporate responsibility with public health innovation. If sustained and expanded, the program could serve as a template for integrating nutrition access into Medicaid managed care contracts or value-based insurance designs.

As insurers, providers, and policymakers increasingly seek cost-effective solutions for chronic disease management, programs like Healthy Food Rx may offer a new frontier—where clinical outcomes are influenced as much by grocery deliveries as by prescriptions.